Logo image of FALG.PA

FERMENTALG (FALG.PA) Stock Fundamental Analysis

EPA:FALG - Euronext Paris - Matif - FR0011271600 - Common Stock - Currency: EUR

0.56  -0.05 (-8.05%)

Fundamental Rating

2

Overall FALG gets a fundamental rating of 2 out of 10. We evaluated FALG against 62 industry peers in the Chemicals industry. FALG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FALG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FALG has reported negative net income.
FALG had a negative operating cash flow in the past year.
In the past 5 years FALG always reported negative net income.
FALG had a negative operating cash flow in each of the past 5 years.
FALG.PA Yearly Net Income VS EBIT VS OCF VS FCFFALG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The Return On Assets of FALG (-17.18%) is worse than 90.48% of its industry peers.
FALG has a Return On Equity of -27.38%. This is amonst the worse of the industry: FALG underperforms 82.54% of its industry peers.
Industry RankSector Rank
ROA -17.18%
ROE -27.38%
ROIC N/A
ROA(3y)-14.94%
ROA(5y)-22.44%
ROE(3y)-23.99%
ROE(5y)-37.74%
ROIC(3y)N/A
ROIC(5y)N/A
FALG.PA Yearly ROA, ROE, ROICFALG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80

1.3 Margins

The Gross Margin of FALG (23.21%) is worse than 65.08% of its industry peers.
FALG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FALG.PA Yearly Profit, Operating, Gross MarginsFALG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -1K -2K -3K -4K -5K

More info and screens

4

2. Health

2.1 Basic Checks

FALG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FALG has been increased compared to 1 year ago.
Compared to 1 year ago, FALG has a worse debt to assets ratio.
FALG.PA Yearly Shares OutstandingFALG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
FALG.PA Yearly Total Debt VS Total AssetsFALG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.67, we must say that FALG is in the distress zone and has some risk of bankruptcy.
FALG has a Altman-Z score of 0.67. This is amonst the worse of the industry: FALG underperforms 87.30% of its industry peers.
FALG has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.43, FALG perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACCN/A
WACC5.28%
FALG.PA Yearly LT Debt VS Equity VS FCFFALG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M 40M

2.3 Liquidity

FALG has a Current Ratio of 5.35. This indicates that FALG is financially healthy and has no problem in meeting its short term obligations.
FALG has a Current ratio of 5.35. This is amongst the best in the industry. FALG outperforms 93.65% of its industry peers.
A Quick Ratio of 3.76 indicates that FALG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.76, FALG belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.35
Quick Ratio 3.76
FALG.PA Yearly Current Assets VS Current LiabilitesFALG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

FALG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.64%.
The Revenue for FALG has decreased by -43.16% in the past year. This is quite bad
Measured over the past years, FALG shows a very strong growth in Revenue. The Revenue has been growing by 114.10% on average per year.
EPS 1Y (TTM)-32.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.89%
Revenue 1Y (TTM)-43.16%
Revenue growth 3Y59.41%
Revenue growth 5Y114.1%
Sales Q2Q%-55.35%

3.2 Future

FALG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.96% yearly.
The Revenue is expected to grow by 29.38% on average over the next years. This is a very strong growth
EPS Next Y4%
EPS Next 2Y9.54%
EPS Next 3Y13.96%
EPS Next 5YN/A
Revenue Next Year-49.05%
Revenue Next 2Y12.86%
Revenue Next 3Y29.38%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FALG.PA Yearly Revenue VS EstimatesFALG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
FALG.PA Yearly EPS VS EstimatesFALG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FALG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FALG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FALG.PA Price Earnings VS Forward Price EarningsFALG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FALG.PA Per share dataFALG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as FALG's earnings are expected to grow with 13.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.54%
EPS Next 3Y13.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FALG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FERMENTALG

EPA:FALG (4/15/2024, 7:00:00 PM)

0.56

-0.05 (-8.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.22M
Analysts42.22
Price Target0.36 (-35.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-77.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-5.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)-19.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.02
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.11
BVpS0.87
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.18%
ROE -27.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.21%
FCFM N/A
ROA(3y)-14.94%
ROA(5y)-22.44%
ROE(3y)-23.99%
ROE(5y)-37.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.79%
Cap/Sales 16.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.35
Quick Ratio 3.76
Altman-Z 0.67
F-Score2
WACC5.28%
ROIC/WACCN/A
Cap/Depr(3y)166.86%
Cap/Depr(5y)108.82%
Cap/Sales(3y)52.01%
Cap/Sales(5y)108.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.89%
EPS Next Y4%
EPS Next 2Y9.54%
EPS Next 3Y13.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-43.16%
Revenue growth 3Y59.41%
Revenue growth 5Y114.1%
Sales Q2Q%-55.35%
Revenue Next Year-49.05%
Revenue Next 2Y12.86%
Revenue Next 3Y29.38%
Revenue Next 5YN/A
EBIT growth 1Y-8.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.67%
EBIT Next 3Y19.06%
EBIT Next 5YN/A
FCF growth 1Y-24.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.86%
OCF growth 3YN/A
OCF growth 5YN/A